HIV Activists Take to the Stage at 'Research 4 Prevention' Opening to Demand Continued Funding of Wider Prevention Research Agenda
Activists and public health professionals took to the stage during the opening plenary of the Research for HIV Prevention (HIVR4P) conference yesterday to challenge U.S. government research agencies and demand support for short-acting, user-controlle...
"It is every bit as absurd as it sounds," Mark S. King writes. "The International AIDS Society (IAS) plans to hold their global AIDS2020 conference in San Francisco -- an insanely expensive and privileged city located in a country that has become dan...
Mark S. King tells us what at this year's USCA made the biggest impact on him and his work as an HIV advocate.
Tips for activists to prepare for high-level meetings, on the heels of news about black ministers meeting with Trump on prison reform.
HIV Activists Launch #BreakThePatent Campaign and National Plan for Generics and Lower-Cost Truvada for HIV Prevention in the U.S.
NYC-based HIV activists Jason Walker and Emily Sanderson think that, just like the cost of rent, pre-exposure prophylaxis PrEP is too damn expensive.
How do community-based organizations see using Pride as a place for HIV education and information in the 21st century?
Gilead Sciences is coming under fire from HIV/AIDS activist groups for a recent change to its patient assistance program, imposing a once-per-lifetime limit on access to Truvada as part of non-occupational post-exposure prophylaxis (nPEP).
The framework to build a racially just and strategic HIV movement addresses root causes of the epidemic and lights a new way forward.
Activist Peter Staley shares his perspective with Mark S. King about why street activism is not only a right, but an obligation.
To support the efforts of prevention advocates across the U.S., Treatment Action Group has developed a series of modules to help support activists' capacity needs and to develop advocacy action plans.